← All trials
NCT02950883
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2016
- Primary completion
- Feb 1, 2019
- Completion date
- Apr 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of WashingtonLead sponsor
- University of TorontoOverall official - principal investigator
- Indiana UniversityOverall official - principal investigator
- University of WashingtonOverall official - principal investigator
- Telethon Institute for Child Health ResearchOverall official - principal investigator
- Cystic Fibrosis Foundation TherapeuticsCollaborator
- Erasmus University RotterdamOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.